Immunoblastic Lymphadenopathy (Lymphadenopathy, Angioimmunoblastic)

Subscribe to Selected New Research on Immunoblastic Lymphadenopathy

191 relevant articles (9 outcomes, 7 trials/studies) found for this Disease

Description: A disorder characterized by proliferation of arborizing small vessels, prominent immunoblastic proliferations and amorphous acidophilic interstitial material. Clinical manifestations include fever, sweats, weight loss, generalized lymphadenopathy and frequently hepatosplenomegaly.

Also Known As:

Lymphadenopathy, Angioimmunoblastic; Angioimmunoblastic Lymphadenopathy; Angioimmunoblastic Lymphadenopathies; Immunoblastic Lymphadenopathies; Lymphadenopathies, Angioimmunoblastic; Lymphadenopathies, Immunoblastic; Lymphadenopathy, Immunoblastic

Relationship Network

Disease Context: Research Results

Hemic and Lymphatic Diseases

Lymphatic Diseases: 1961

Lymphoproliferative Disorders: 2359

Immunoblastic Lymphadenopathy: 191

Immune System Diseases: 1319

Immunoproliferative Disorders: 26

Lymphoproliferative Disorders: 2359

Immunoblastic Lymphadenopathy: 191

Related Diseases

1.	T-Cell Lymphoma (Lymphoma, T Cell)
2.	Lymphoma (Lymphomas)
3.	Lymphatic Diseases (Lymphadenopathy)
4.	Hypergammaglobulinemia (Hyperimmunoglobulinemia)
5.	Myelodysplastic Syndromes (Myelodysplastic Syndrome)

Experts

1.	Barbera, V: 2 articles (01/2001 - 08/2000)
2.	Mariani, G: 2 articles (01/2001 - 08/2000)
3.	Florena, A M: 2 articles (01/2001 - 08/2000)
4.	Franco, V: 2 articles (01/2001 - 08/2000)
5.	Joly, P: 1 article (05/2006)
6.	Levesque, H: 1 article (05/2006)
7.	Courville, P: 1 article (05/2006)
8.	Sellier, S: 1 article (05/2006)
9.	Bourikas, George: 1 article (01/2003)
10.	Batinac, Tanja: 1 article (01/2003)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Immunoblastic Lymphadenopathy:

1.	Interferon-alpha (Interferon Alfa)FDA Link 10/01/1991 - "Interferon-alpha induces complete remission in angioimmunoblastic lymphadenopathy (AILD): late development of aplastic anaemia with cytokine abnormalities." 10/01/1991 - "Recombinant human interferon-alpha in the treatment of angioimmunoblastic lymphadenopathy: results in 12 patients." 09/15/1988 - "Alpha-interferon in angioimmunoblastic lymphadenopathy." 07/01/1987 - "Alpha-interferon therapy in refractory angioimmunoblastic lymphadenopathy." 04/01/1994 - "Interferon alpha holds its place in the treatment of skin lymphomas where it leads in a great proportion of lymphomas to remission, and in angioimmunoblastic lymphadenopathy. " Order ALL the reference details at left...
2.	Prednisone (Sone)FDA LinkGeneric 03/03/1979 - "Prednisone in treatment of allergen-associated angio-immunoblastic lymphadenopathy." 09/01/1992 - "OBJECTIVE: To describe the clinical course of patients with angioimmunoblastic lymphadenopathy (AILD)-type lymphoma with a sequential treatment with prednisone and COPBLAM/IMVP-16. " 09/01/1992 - "Treatment of angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma using prednisone with or without the COPBLAM/IMVP-16 regimen. " 05/01/2006 - "CASE REPORT: A 62 year-old man with angioimmunoblastic lymphadenopathy was treated with oral prednisone (15 mg/day) and cyclophosphamide. " 05/13/1994 - "Treatment with prednisone (2 mg/kg daily for 8 weeks) and vincristine (1 mg/m2 once weekly for 4 weeks) brought about partial remission of the angioimmunoblastic lymphadenopathy with normalization of the clinical and laboratory findings, the splenohepatomegaly regressed, and there was only a small amount of ascites. " Order ALL the reference details at left...
3.	Vincristine (Oncovin)FDA LinkGeneric 05/13/1994 - "Treatment with prednisone (2 mg/kg daily for 8 weeks) and vincristine (1 mg/m2 once weekly for 4 weeks) brought about partial remission of the angioimmunoblastic lymphadenopathy with normalization of the clinical and laboratory findings, the splenohepatomegaly regressed, and there was only a small amount of ascites. " 01/01/1983 - "Therapeutic effect of vincristine, adriamycin and prednisolone (VAP) in angioimmunoblastic lymphadenopathy (AIL)." Order ALL the reference details at left...
4.	Prednisolone (Predate)FDA LinkGeneric 05/15/1981 - "[Disease-specific renal failure in angioimmunoblastic lymphadenopathy - remission by high dose prednisolone. " 01/01/1983 - "Therapeutic effect of vincristine, adriamycin and prednisolone (VAP) in angioimmunoblastic lymphadenopathy (AIL)." Order ALL the reference details at left...
5.	InterferonsIBA 01/01/1991 - "Improved response to chemotherapy after interferon alpha-2b in angioimmunoblastic lymphadenopathy (AILD)" 01/01/1987 - "Plasma samples of patients with angioimmunoblastic lymphadenopathy (AIBL) were tested for anti-HTLV antibodies and for interferon content. " Order ALL the reference details at left...
6.	Antinuclear AntibodiesIBA 06/01/2001 - "The clinical characteristics resembled angioimmunoblastic lymphadenopathy: spontaneous regression of lymphadenopathy and immunological abnormalities such as polyclonal hypergammaglobulinemia, positive results of direct and indirect antiglobulin tests, and a high antinuclear antibody titer. " Order ALL the reference details at left...
7.	antineoplaston A10 (A 10)IBA 07/24/1993 - "We saw a 24-year-old female patient with a fulminant evolution of an angioimmunoblastic lymphadenopathy, possibly a recurrence after a 10 years remission." Order ALL the reference details at left...
8.	AntigensIBA 12/17/1979 - "The presence of rubella virus antigen was demonstrated by means of immunohistological methods in two cases of angioimmunoblastic lymphadenopathy. " 09/01/1979 - "Rubella virus antigen in lymphocytes of patients with angioimmunoblastic lymphadenopathy (AIL)." 08/01/1990 - "Kaposi's sarcoma, angioimmunoblastic lymphadenopathy, and antibody to HIV-1 p24 antigen in a patient nonreactive for HIV-1 with use of ELISA." 05/01/1989 - "Angioimmunoblastic lymphadenopathy is usually characterized as a lymphoproliferative disease caused by an abnormal reaction to various chemical and biological antigens and the possible development into malignant lymphomas of different types. " 12/01/1977 - "Immunoblastic lymphadenopathy may represent a syndrome in which the adenopathy is but a nonspecific part of a systemic hyperimmune response to unknown antigens. " Order ALL the reference details at left...
9.	Interleukin-6 (Interleukin 6)IBA 02/01/1993 - "Pathogenic significance of interleukin-6 in angioimmunoblastic lymphadenopathy-type T-cell lymphoma." 11/01/1998 - "[Immunoblastic lymphadenopathy-like T cell lymphoma with high levels of serum interleukin-6, cold agglutinin disease, and immune thrombocytopenia]" 09/01/1996 - "Increased levels of interleukin-6 (IL-6) in serum and spontaneous in vitro production of IL-6 by lymph node mononuclear cells of patients with angio-immunoblastic lymphadenopathy with dysproteinemia (AILD), and clinical effectiveness of cyclosporin A." 10/01/1993 - "For example, IL-4 is responsible for the T-cell reaction in T-cell-rich B-cell lymphoma, while IL-6 is accountable for the plasma cell reaction in angioimmunoblastic lymphadenopathy-type T-cell lymphoma. " 01/01/1996 - "Studies on a patient with angio-immunoblastic lymphadenopathy, another disease showing haematopoietic insufficiency, who developed severe aplastic anaemia, showed massive increases in IFN gamma and TNF alpha levels in serum; IL-6 and GM-CSF levels were below the limit of detection. " Order ALL the reference details at left...
10.	Phenytoin (Dilantin)FDA LinkGeneric 01/01/1990 - "The importance of this study is the association that may exist between certain drugs and the development of angioimmunoblastic lymphadenopathy, which occurred in our patient with the use of diphenylhydantoin. " 11/01/1981 - "Angioimmunoblastic lymphadenopathy in a patient taking diphenylhydantoin." 03/01/1996 - "In this article, five cases of multiple myeloma and one of immunoblastic lymphadenopathy associated with diclonal gammopathy diagnosed after longterm phenytoin therapy are reviewed. " 10/01/1979 - "This concept is based on two different lines of experimental evidence: (1) results obtained with animal graft-versus-host reactions, in which immunoblastic lymphadenopathy, angiogenesis, dermatitis and multiple autoantibody formation are known to be induced by reactions of parental T lymphocytes toward genetically foreign structures of the major histocompatibility complex; (2) experiments pointing to an essential similarity in T-cell reactions toward genetically foreign major histocompatibility structures on the one hand and self-major histocompatibility structures that were rendered "foreign" by viruses or chemicals on the other hand; (3) recent findings in mice that demonstrate a T-cell-dependent lymphoproliferation after the administration of diphenylhydantoin." 11/01/1981 - "The premise that chronic antigenic stimulation may be involved in lymphoproliferative disorders was considered in a patient with angioimmunoblastic lymphadenopathy who had received diphenylhydantoin (DPH) for seizure. " Order ALL the reference details at left...

Therapies and Procedures

1.	Drug Therapy (Chemotherapy) 01/01/1983 - "A patient with angioimmunoblastic lymphadenopathy was treated with chemotherapy to complete remission for 13 years. " 09/01/1988 - "The peptide and the red cell autoantibody disappeared in a patient with angio-immunoblastic lymphadenopathy with dysproteinaemia (AILD) after intensive chemotherapy. " 01/01/1983 - "She later developed angioimmunoblastic lymphadenopathy (AIL) which became progressively resistant to chemotherapy. " 09/01/1976 - "The cases illustrate the ineffectiveness and possible adverse effect of chemotherapy, as well as the importance of differentiation of immunoblastic lymphadenopathy from frankly malignant lymph node diseases." 12/01/1991 - "High-dose chemotherapy and autologous bone marrow transplantation in relapsing angioimmunoblastic lymphadenopathy with dysproteinemia (AILD)." Order ALL the reference details at left...
2.	Combination Drug Therapy (Combination Chemotherapy) 01/01/1986 - "A short-term in vitro chemosensitivity test could predict response to COP combination chemotherapy suggesting that in vitro chemosensitivity testing can be useful for the therapeutic management of angioimmunoblastic lymphadenopathy." 12/31/1982 - "Cutaneous and visceral dissemination of Kaposi's sarcoma (KS) occurred in a patient with angioimmunoblastic lymphadenopathy with dysproteinemia (AILD) who had been treated with combination chemotherapy. " 01/15/1981 - "In a longitudinal study, several immunologic in vitro tests were performed on peripheral lymphocytes in four patients with immunoblastic lymphadenopathy during sequential therapy with Levamisole and polychemotherapy. " 06/01/1991 - "We experienced a remarkable effect of recombinant interferon alpha 2a (alpha-IFN) in a case of angioimmunoblastic lymphadenopathy with dysproteinemia (AILD) which was refractory to steroids and combination chemotherapies. " 06/01/1991 - "[A remarkable effect of alpha-interferon in a case of angioimmunoblastic lymphadenopathy with dysproteinaemia (AILD) refractory to steroids and combination chemotherapies]" Order ALL the reference details at left...
3.	Transplants (Transplant) 12/01/1985 - "BALB/c mice neonatally injected with (BALB/c X C57BL/6)F1 hybrid spleen cells develop host-versus-graft disease (HVGD) with immunopathological features characteristic of either systemic lupus erythematosus (SLE), or immunoblastic lymphadenopathy (IBL) in man. " 01/01/1981 - "Attempts to transplant tumor from 17 patients with Hodgkin's disease or 4 patients with immunoblastic lymphadenopathy were unsuccessful. " 10/01/1979 - "This concept is based on two different lines of experimental evidence: (1) results obtained with animal graft-versus-host reactions, in which immunoblastic lymphadenopathy, angiogenesis, dermatitis and multiple autoantibody formation are known to be induced by reactions of parental T lymphocytes toward genetically foreign structures of the major histocompatibility complex; (2) experiments pointing to an essential similarity in T-cell reactions toward genetically foreign major histocompatibility structures on the one hand and self-major histocompatibility structures that were rendered "foreign" by viruses or chemicals on the other hand; (3) recent findings in mice that demonstrate a T-cell-dependent lymphoproliferation after the administration of diphenylhydantoin." Order ALL the reference details at left...
4.	Aftercare (After-Treatment) 10/01/1987 - "A case is presented of a 68-year-old woman with the classical form of cutaneous KS in whom disappearance of the lesions after treatment was shortly followed by the development of angioimmunoblastic lymphadenopathy, pursuing a fulminant course to death. " 09/01/1983 - "Hodgkin's disease in a patient after treatment for angioimmunoblastic lymphadenopathy." Order ALL the reference details at left...
5.	Bone Marrow Transplantation (Transplantation, Bone Marrow) 12/01/1991 - "High-dose chemotherapy and autologous bone marrow transplantation in relapsing angioimmunoblastic lymphadenopathy with dysproteinemia (AILD)." Order ALL the reference details at left...

Best Treatments:
Research Summary Report
on Immunoblastic Lymphadenopathy

*WARNING* This specific disease subtype has a relatively small number of significant evidence outcomes. You may proceed to order anyway, or go back to the search field and enter a more general type of the target illness. Once your report has been ordered, however, we can't refund the purchase.

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 9 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>